Riskpilot← Back to searchSign inGet full accessIO BIOTECH ApS
APSBankruptCVR 36474483Ole Maaløes Vej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 201414 employees
Revenue 2024
—
EBITDA margin
—
-8% vs 2023
Equity ratio
-9.9%
Financial strength
Net profit 2024
DKK -84,8M
-11% vs 2023
| Revenue | — | — |
| EBITDA | DKK -83,8M | -8% |
| Net profit | DKK -84,8M | -11% |
| Total assets | DKK 67M | +14% |
| Equity | DKK -6,6M | -136% |
| Employees | 14 | — |
Legal name
IO BIOTECH ApS
CVR number
36474483
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. december 2014
Share capital
DKK 2.830.616
Employees
14 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er udvikling af en vaccine rettet imod immumhæmmende celler alt med henblik på forebyggelse og/eller behandling af cancer, samt hermed efter bestyrelsens skøn beslægtede formål.
Address
Ole Maaløes Vej 3
Email
info@iobiotech.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | 0 | 0 | — | — |
| Staff expenses | -1.215 | -3.441 | -0 | -0 | -16.381 | -0 | -55.110 | -0 | -0 | -0 |
| EBITDA | -3.881 | -15.102 | -30.534 | -54.357 | -71.516 | -69.183 | -242.325 | -467.606 | -77.824 | -83.800 |
| Depreciation & amort. | -0 | -0 | -81 | -108 | -151 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3.881 | -15.102 | -30.616 | -54.464 | -71.667 | -69.183 | -242.325 | -467.606 | -77.824 | -83.800 |
| Net financials | -36 | -40 | 8 | -2.363 | -2.510 | -1.478 | -3.586 | -931 | 437 | -1.771 |
| Profit before tax | -3.917 | -15.143 | -30.608 | -56.827 | -74.177 | -70.661 | -245.911 | -468.537 | -77.387 | -85.571 |
| Tax | -667 | -2.820 | -5.500 | -5.500 | -5.500 | -5.500 | -5.500 | -5.500 | -738 | -737 |
| Net profit | -3.250 | -12.322 | -25.108 | -51.327 | -68.677 | -65.161 | -240.411 | -463.037 | -76.649 | -84.834 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 20.037 | 73.693 | 49.584 | 63.784 | 63.170 | 36.096 | 803.145 | 417.028 | 59.039 | 67.017 |
| Equity | 18.593 | 69.391 | 44.284 | 54.812 | -13.865 | 17.536 | 722.779 | 259.741 | 18.203 | -6.630 |
| Long-term debt | 0 | 0 | 0 | 0 | 339 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.444 | 4.301 | 5.300 | 8.971 | 76.696 | 18.560 | 80.367 | 157.286 | 40.835 | 73.648 |
| Total debt | 1.444 | 4.301 | 5.300 | 8.971 | 77.035 | 18.560 | 80.367 | 157.286 | 40.835 | 73.648 |
EBITDA margin
-8380041900.0%
This company
15.8%
Market median
-53038239973% vs market
20152024
Equity ratio
-9.9%
This company
38.2%
Market median
-126% vs market
20152024
Return on equity
-8483363500.0%
This company
18.4%
Market median
-46105236513% vs market
20152024
Net profit margin
-8483363500.0%
This company
8.1%
Market median
-104732882816% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
11.11×
This company
0.62×
Market median
-1692% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-12-23 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MZ Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2015 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 | |
SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | Company | 5.0% | 5.0% | 2021 |
Novo Holdings A/S | Company | 15.0% | 15.0% | 2021 |
| Individual | 10.0% | 10.0% | 2021 | |
HALD ANDERSEN HOLDING ApS | Company | 5.0% | 5.0% | 2016 |
| Individual | 10.0% | 10.0% | 2021 | |
ZOCCA CONSULTING ApS | Company | 5.0% | 5.0% | 2015 |
| Individual | 5.0% | 5.0% | 2021 | |
| Individual | 5.0% | 5.0% | 2021 | |
RQ SOLUTIONS ApS | Company | 5.0% | 5.0% | 2015 |
THOR STRATEN HOLDING ApS | Company | 5.0% | 5.0% | 2015 |
LUNDBECKFOND INVEST A/S | Company | 20.0% | 20.0% | 2021 |
| Individual | 5.0% | 5.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IO BIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mai-Britt Zocca | Chief Executive Officer | 0 companies |
| Priyanka Belawat | Board of Directors | 0 companies |
| Vanessa Malier | Board of Directors | 0 companies |
| Emmanuelle Coutanceau | Board of Directors | 0 companies |
| Nanna Liebach Lüneborg | Board of Directors | 0 companies |
| Peter Hirth | Chairman | 0 companies |
| Stephan Christgau | Board of Directors | 0 companies |
| Christian Ellebæk Elling | Board of Directors | 0 companies |
| Hans Thalsgård Schambye | Chairman | 0 companies |
| Bo Anders Ljungqvist | Board of Directors | 0 companies |
| Jack Bech Nielsen | Board of Directors | 0 companies |
| Kathleen Sereda Glaub | Board of Directors | 0 companies |
| Claus Asbjørn Andersson | Board of Directors | 0 companies |
| Mads Hald Andersen | Board of Directors | 0 companies |